We have a unique combination of business lines that provide a diverse, future-proof company by leveraging our first-mover advantage to commercialize with broad, immediate revenue stream potential. We are generating revenue now with an expansive near-term revenue plan growing an already robust portfolio of revenue lines while bridging modern science and indigenous traditions. Services provided in two countries and global product distribution/licensing partnerships give us the broadest footprint in the industry.
With biopharmaceutical competition in the psychedelics space being fierce and costly, Silo is a global psychedelics company not dependent on novel molecule clinical trial success. The Marley One mushroom brand and our psychedelic wellness retreats make us a revenue-generating global psychedelics and wellness company delivering psychedelic healing today.